<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T07:08:21Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:10230/27782" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:10230/27782</identifier><datestamp>2026-03-18T01:02:22Z</datestamp><setSpec>com_2072_6</setSpec><setSpec>col_2072_452952</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.</dc:title>
   <dc:creator>Lana, Fernando</dc:creator>
   <dc:creator>Sánchez-Gil, Carmen</dc:creator>
   <dc:creator>Adroher, Núria D.</dc:creator>
   <dc:creator>Pérez Solà, Víctor</dc:creator>
   <dc:creator>Feixas, Guillem</dc:creator>
   <dc:creator>Martí-Bonany, Josep</dc:creator>
   <dc:creator>Torrens, Marta</dc:creator>
   <dc:subject>Trastorn límit de la personalitat</dc:subject>
   <dc:subject>Psicoteràpia</dc:subject>
   <dc:description>BACKGROUND: Concurrent personality disorder (PD) and substance use disorder (SUD) are common in clinical practice. However, SUD is the main criterion for study exclusion in most psychotherapeutic studies of PD. As a result, data on treatment outcomes in patients with concurrent PD/SUD are scarce. METHODS: The study sample consisted of 51 patients diagnosed with severe PD and admitted for psychotherapeutic treatment as a part of routine mental health care. All patients were diagnosed with PD according to the Structured Clinical Interview for PD. Patients were further assessed (DSM-IV diagnostic criteria) to check for the presence of concurrent SUD, with 28 patients diagnosed with both disorders (PD-SUD). These 28 cases were then compared to the 23 patients without SUD (PD-nSUD) in terms of psychiatric hospitalizations and psychiatric emergency room (ER) visits before and during the 6-month therapeutic intervention and every 6 months thereafter for a total of 36 months. RESULTS: The baseline clinical characteristics correspond to a sample of PD patients (78% met DSM-IV criteria for borderline PD) with poor general functioning and a high prevalence of suicide attempts and self-harm behaviors. Altogether, the five outcome variables - the proportion and the number of psychiatric inpatient admissions, the number of days hospitalized, and the proportion and the number of psychiatric ER visits - improved significantly during the treatment period, and this improvement was maintained throughout the follow-up period. Although PD-SUD patients had more psychiatric hospitalizations and ER visits than PD-nSUD patients during follow-up, the differences between these two groups remained stable over the study period indicating that the treatment was equally effective in both groups. CONCLUSION: Specialized psychotherapy for severe PD can be effectively applied in patients with concurrent PD-SUD under usual practice conditions. These findings suggest that exclusion of patients with dual disorders from specialized treatments is unjustified.</dc:description>
   <dc:date>2016-12-16T11:10:34Z</dc:date>
   <dc:date>2016-12-16T11:10:34Z</dc:date>
   <dc:date>2016</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Lana F, Sánchez-Gil C, Adroher ND, Pérez V, Feixas G, Martí-Bonany J. et al.  Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study. Neuropsychiatr Dis Treat. 2016 Jun 21;12:1477-87. doi: 10.2147/NDT.S106270</dc:identifier>
   <dc:identifier>1176-6328</dc:identifier>
   <dc:identifier>http://hdl.handle.net/10230/27782</dc:identifier>
   <dc:identifier>http://dx.doi.org/10.2147/NDT.S106270</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Neuropsychiatric Disease and Treatment. 2016 Jun 21;12:1477-87</dc:relation>
   <dc:rights>© 2016 Lana et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by-nc/3.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Dove Medical Press</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>